All Stories

  1. Effect of ABO blood group on immune checkpoint inhibitors

    Article • Cancer Biomarkers, May 2022, IOS Press

    Assoc. Prof. Yakup Ergun

  2. First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal carcinoma

    Article • Bosnian Journal of Basic Medical Sciences, April 2022, Association of Basic Medical Sciences of FBIH

    Assoc. Prof. Yakup Ergun

  3. An Overview of Seminomatous and Non-Seminomatous Germ Cell Testicular Tumors: A Single-center Experience

    Article • Bulletin of Urooncology, December 2021, Journal of Clinical Research of Pediatric Endocrinology

    Assoc. Prof. Yakup Ergun

  4. Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy

    Article • Future Oncology, November 2021, Future Medicine

    Assoc. Prof. Yakup Ergun

  5. Role of hepatosteatosis in HBsAg seroconversion in HBeAg‐negative chronic hepatitis B patients

    Article • International Journal of Clinical Practice, September 2021, Hindawi Publishing Corporation

    Assoc. Prof. Yakup Ergun

  6. Anxiety, Insomnia and Pandemic Awareness of Cancer Patients Receiving Chemotherapy During the COVID-19 Pandemic Period

    Article • International Journal of Hematology and Oncology, July 2021, Akademi Doktorlar Yayinevi

    Assoc. Prof. Yakup Ergun

  7. Is It Safe to Use Long-Acting G-CSF for Febrile Neutropenia Prophylaxis in COVID-19 Pandemic?

    Article • JCO Oncology Practice, July 2021, American Society of Clinical Oncology (ASCO)

    Assoc. Prof. Yakup Ergun

  8. P-85 Relationship between microsatellite instability and neoadjuvant chemotherapy response in gastric or gastroesophageal junction cancer: A meta-analysis

    Article • Annals of Oncology, July 2021, Elsevier

    Assoc. Prof. Yakup Ergun

  9. Esophageal Involvement and Gastroesophageal Reflux Disease in Systemic Sclerosis: A Tertiary Center Experience

    Article • Journal of Contemporary Medicine, May 2021, Cagdas Tip Dergisi: Journal of Contemporary Medicine

    Assoc. Prof. Yakup Ergun

  10. The Comparison of mDCF and mFOLFOX-6 as First-Line Treatment in Metastatic Gastric Cancer

    Article • Cureus, May 2021, Cureus, Inc.

    Assoc. Prof. Yakup Ergun

  11. Tamoxifen in breast cancer survivors with COVID 19: stop or go?

    Article • Medical Oncology, March 2021, Springer Science + Business Media

    Assoc. Prof. Yakup Ergun

  12. Is there any clinical or laboratory predictive factor for cetuximab-induced skin toxicity?

    Article • Expert Opinion on Drug Safety, March 2021, Taylor & Francis

    Assoc. Prof. Yakup Ergun

  13. Efficacy and Safety of Neoadjuvant Immunotherapy in Triple Negative Breast Cancer: Meta-analysis of randomized controlled trials

    Article • March 2021, Research Square

    Assoc. Prof. Yakup Ergun

  14. Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group

    Article • Journal of Gastrointestinal Cancer, February 2021, Springer Science + Business Media

    Assoc. Prof. Yakup Ergun, Dr suleyman sahin

  15. Saying goodbye to primary endocrine resistance for advanced breast cancer?

    Article • Medical Oncology, January 2021, Springer Science + Business Media

    Assoc. Prof. Yakup Ergun

  16. A Comparison of Osseous and Extraosseous Ewing Sarcoma

    Article • Journal of College of Physicians And Surgeons Pakistan, January 2021, College of Physicians and Surgeons Pakistan

    Assoc. Prof. Yakup Ergun

  17. Systemic treatment options for growing teratoma syndrome: A single-center experience with a comprehensive review of the literature

    Article • Journal of Cancer Research and Therapeutics, January 2021, Medknow

    Assoc. Prof. Yakup Ergun

  18. Neoadjuvan Kemoterapi Alan Lokal İleri Mide Kanserli Hastalarda Primer Tümör Lokalizasyonunun Önemi

    Article • Dicle Medical Journal / Dicle Tip Dergisi, December 2020, Dicle Medical Journal/Dicle Tip Dergisi

    Assoc. Prof. Yakup Ergun

  19. Opere Pankreas Adenokanserli Hastalarda Kemoterapiye Kemoradyoterapi Eklemenin Katkısı

    Article • Dicle Medical Journal / Dicle Tip Dergisi, December 2020, Dicle Medical Journal/Dicle Tip Dergisi

    Assoc. Prof. Yakup Ergun

  20. The prognostic value of tumor/lymph node standardized uptake value max ratio and correlation with hematologic parameters in stage III nonsmall cell lung cancer

    Article • Medicine, November 2020, Wolters Kluwer Health

    Assoc. Prof. Yakup Ergun

  21. Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer

    Article • Tumori Journal, November 2020, SAGE Publications

    Assoc. Prof. Yakup Ergun

  22. Prognostic and Predictive Value of NAR Score in Gastric Cancer

    Article • Journal of Gastrointestinal Cancer, October 2020, Springer Science + Business Media

    Assoc. Prof. Yakup Ergun

  23. Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer

    Article • Medicine, September 2020, Wolters Kluwer Health

    Assoc. Prof. Yakup Ergun

  24. Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma?

    Article • Cureus, September 2020, Cureus, Inc.

    Assoc. Prof. Yakup Ergun

  25. The Real-Life Data of BRAF Mutation on the Treatment of Colorectal Cancer: a TOG Study

    Article • Journal of Gastrointestinal Cancer, September 2020, Springer Science + Business Media

    Assoc. Prof. Yakup Ergun, İsmail Beypinar

  26. RARE PRESENTATION OF BILE DUCT DILATATION DUE TO BOWEL OBSTRUCTION CAUSED BY A TUMOR IN THE FOURTH PART OF THE DUODENUM

    Article • Gastroenterology Nursing, September 2020, Wolters Kluwer Health

    Assoc. Prof. Yakup Ergun

  27. The effect of chemotherapy on olfactory function and mucociliary clearance

    Article • Supportive Care in Cancer, August 2020, Springer Science + Business Media

    Assoc. Prof. Yakup Ergun

  28. Is there any correlation among MKK4 (mitogen-activated protein kinase kinase 4) expression, clinicopathological features, and KRAS/NRAS mutation in colorectal cancer

    Article • Expert Review of Molecular Diagnostics, July 2020, Taylor & Francis

    Assoc. Prof. Yakup Ergun

  29. HER2-pozitif lokal ileri meme kanserinde neoadjuvan trastuzumab sıralamasının patolojik tam yanıt üzerine etkisi

    Article • Bozok Tıp Dergisi, June 2020, Bozok Tip Dergisi

    Assoc. Prof. Yakup Ergun

  30. Correlation between peripheral blood inflammatory indicators and pathologic complete response to neoadjuvant chemotherapy in locally advanced breast cancer patients

    Article • Medicine, May 2020, Wolters Kluwer Health

    Assoc. Prof. Yakup Ergun

  31. The prognostic value of the prognostic nutritional index in patients with metastatic colorectal cancer

    Article • Asia-Pacific Journal of Clinical Oncology, April 2020, Wiley

    Assoc. Prof. Yakup Ergun

  32. Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?

    Article • Journal of Research in Medical Sciences, January 2020, Medknow

    Assoc. Prof. Yakup Ergun

  33. Characteristics of Patients Who Received Chemotherapy During The Covid 19 Pandemic and Changes in Oncology Practice

    Article • Acta Oncologica Turcica, January 2020, LookUs Bilisim, Ltd.

    Assoc. Prof. Yakup Ergun

  34. The Difference in Clinical and Prognostic Features Between De Novo and Recurrent Her2-Positive Metastatic Breast Cancer Patients

    Article • Acta Medica, December 2019, Hacettepe University - Medical School

    Assoc. Prof. Yakup Ergun

  35. KRAS codon 12 and 13 mutation may guide the selection of irinotecan or oxaliplatin in first-line treatment of metastatic colorectal cancer

    Article • Expert Review of Molecular Diagnostics, November 2019, Taylor & Francis

    Assoc. Prof. Yakup Ergun

  36. Subakut tiroidit tanılı hastaların demografik özellikleri ve laboratuvar verilerinin analizi: tek merkez deneyimi

    Article • Ege Tıp Dergisi, September 2019, Ege Journal of Medicine

    Assoc. Prof. Yakup Ergun

  37. Correlation betwen MKK4 expression (exp) and clinicopathological features, KRAS/NRAS mutation in metastatic colorectal cancer (mCRC).

    Article • Journal of Clinical Oncology, May 2019, American Society of Clinical Oncology (ASCO)

    Assoc. Prof. Yakup Ergun

  38. Retrospective Analysis of Demographic and Laboratory Data of Patients with Hepatocellular Carcinoma: Single Center Experience

    Article • Acta Oncologica Turcica, January 2019, LookUs Bilisim, Ltd.

    Assoc. Prof. Yakup Ergun

  39. The comparison of oxaliplatin or irinotecan rechallenge treatment with regorafenib in the third-line treatment of metastatic colorectal cancer

    Article • Acta Oncologica Turcica, January 2019, LookUs Bilisim, Ltd.

    Assoc. Prof. Yakup Ergun

  40. Trichomegaly associated with panitumumab: Case report

    Article • Acta Oncologica Turcica, January 2018, LookUs Bilisim, Ltd.

    Assoc. Prof. Yakup Ergun

  41. Gastric Cancer Patients with Bone Marrow Metastasis: A Single-Center Experience and Review of the Literature

    Article • Eurasian Journal of Medicine and Oncology, January 2017, Kare Publishing

    Assoc. Prof. Yakup Ergun